[{"data":1,"prerenderedAt":158},["ShallowReactive",2],{"drug-triamcinolone-cream":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":22,"regimens":35,"contraindications":53,"warnings":63,"renal":71,"monitoring":72,"interactions":73,"review":74,"examples":77,"atc":83,"iran":85,"links":113,"populations":128,"usApproval":153},"triamcinolone-cream",1,{"fa":7,"en":8},"کرم تریامسینولون","Triamcinolone cream","dermatology",{"fa":11,"en":12},"کورتیکواستروئید موضعی متوسط","Medium-potency topical corticosteroid",[14],{"name":15,"market":16},"Kenalog","US",[18,19,20,21],"kenalog","کنالوگ","تریامسینولون","کرم کورتون",[23],{"id":24,"form":25,"route":26,"label":27,"concentration":28,"markets":30,"refs":31},"cream-0-1","cream","topical","0.1% cream",{"amount":5,"unit":29,"perUnit":29},"application",[16],[32],{"source":33,"section":34},"fda-triamcinolone","How Supplied",[36],{"id":37,"disease":38,"label":39,"population":42,"type":43,"unit":29,"dose":44,"refs":46,"limits":49},"derm","dermatitis",{"fa":40,"en":41},"درماتوز پاسخ‌ده به کورتون — دو تا سه بار در روز","Steroid-responsive dermatoses — two to three times daily",{},"fixed",{"perDose":5,"dosesPerDay":45},2,[47],{"source":33,"section":48},"Dosage and Administration",{"maxPerDay":50,"refs":51},3,[52],{"source":33,"section":48},[54],{"id":55,"severity":56,"text":57,"refs":60},"ci","block",{"fa":58,"en":59},"حساسیت به اجزا.","Hypersensitivity to any component.",[61],{"source":33,"section":62},"Contraindications",[64],{"text":65,"refs":68},{"fa":66,"en":67},"کودکان به سرکوب محور HPA و کوشینگ حساس‌ترند؛ کمترین مقدار مؤثر.","Children are more susceptible to HPA-axis suppression and Cushing’s; use the least effective amount.",[69],{"source":33,"section":70},"Pediatric Use",[],[],[],{"status":75,"reviewer":76,"date":76},"unverified",null,[78],{"regimen":37,"formulation":24,"input":79,"expect":82},{"ageYears":80,"weightKg":81},30,70,{"perDose":5},[84],"D07AB09",{"status":86,"forms":87,"refs":108},"registered",[88,92,96,100,104],{"code":89,"en":90,"fa":91},"01248","TRIAMCINOLONE ACETONIDE 0.1% 15G CREAM","کرم تریامسینولون استوناید ۰٫۱ درصد ۱۵ گرم",{"code":93,"en":94,"fa":95},"01249","TRIAMCINOLONE ACETONIDE 0.1% 15G OINT","پماد تریامسینولون استوناید ۰٫۱ درصد ۱۵ گرم",{"code":97,"en":98,"fa":99},"01250","TRIAMCINOLONE ACETONIDE 0.1% MOUTH GEL","ژل تریامسینولون استوناید ۰٫۱ درصد دهان",{"code":101,"en":102,"fa":103},"06478","TRIAMCINOLONE ACETONIDE 0.1% MOUTH PASTE","خمیر تریامسینولون استوناید ۰٫۱ درصد دهان",{"code":105,"en":106,"fa":107},"02202","TRIAMCINOLONE ACETONIDE 0.1% TOP GEL","ژل موضعی تریامسینولون استوناید ۰٫۱ درصد",[109],{"source":110,"section":111,"url":112},"darooyab-generic","G-4590\u002FTriamcinolone-Topical","https:\u002F\u002Fwww.darooyab.ir\u002FG-4590\u002FTriamcinolone-Topical",[114,118,122,125],{"kind":115,"url":116,"label":117},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=208848","ANDA208848",{"kind":119,"url":120,"label":121},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=db87426f-124c-4ea9-bb15-fc3a0da10a4e","FDA Triamcinolone cream",{"kind":123,"url":124,"label":84},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=D07AB09",{"kind":126,"url":112,"label":127},"darooyab","Triamcinolone-Topical",{"pregnancy":129,"lactation":138,"pediatric":146},{"level":130,"text":131,"quote":134,"refs":135},"caution",{"fa":132,"en":133},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.",[136],{"source":33,"section":137},"Pregnancy: Teratogenic Effects",{"level":130,"text":139,"quote":142,"refs":143},{"fa":140,"en":141},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Nevertheless, caution should be exercised when topical corticosteroids are administered to a nursing woman.",[144],{"source":33,"section":145},"Nursing Mothers",{"level":130,"text":147,"quote":150,"refs":151},{"fa":148,"en":149},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio.",[152],{"source":33,"section":70},{"kind":154,"refs":155,"id":117},"ANDA",[156],{"source":33,"section":157},"SPL approval \u002F marketing category",1792191869323]